Laurus Labs Q2 net profit surges on 33% rise in revenue
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
· 10/29/2026, 3:18:06 PM· 2 min read
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
Read original story →Related stories
business
Microsoft expands AI infrastructure, adds 24 data centres to its 500-plus global kitty in Q1 FY27
business
LANXESS, BPCL join hands to develop next-gen lubricant solutions
business
Deepavali sales expected to gain momentum in Coimbatore next week
business